Ying-Nai Wang

4PUBLICATIONS
29CO-AUTHORS
Molecular targetsPredictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 11, 2026
All-trans retinoic acid destabilizes ADAR1 protein through retinoylation-mediated USP7 dissociation and improves immunotherapy in pancreatic cancer.

|Feb 02, 2024
Targeting ALK averts ribonuclease 1-induced immunosuppression and enhances antitumor immunity in hepatocellular carcinoma.

Chunxiao Liu, Chenhao Zhou, Weiya Xia

|Oct 17, 2022
Targeting the ALK-CDK9-Tyr19 kinase cascade sensitizes ovarian and breast tumors to PARP inhibition via destabilization of the P-TEFb complex.

Yu-Yi Chu, Mei-Kuang Chen, Yongkun Wei

|May 14, 2021
Human ribonuclease 1 serves as a secretory ligand of ephrin A4 receptor and induces breast tumor initiation.

Heng-Huan Lee, Ying-Nai Wang, Wen-Hao Yang

Pageof 1

Frequent Collaborators

4 joint publications

Heng-Huan Lee

4 joint publications

Mien-Chie Hung

3 joint publications

Shao-Chun Wang

3 joint publications

Dihua Yu